Association between 5α-reductase inhibitors therapy and incidence, cancer-specific mortality, and progression of prostate cancer: evidence from a meta-analysis

Por Lian-Min Luo, Re-Dian Yang, Jia-Min Wang, Shan-Kun Zhao, Yang-Zhou Liu, Zhi-Guo Zhu, Qian Xiang, Zhi-Gang Zhao
Publicado em 2020-01-01